Related in Medical Technology

Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)

THOUSAND OAKS, Calif., Aug. 3 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN ) today announced positive top-line results from a pivotal Phase 3 head-to-head trial evaluating denosumab administered subcutaneously versus Zometa((R)) (zoledronic acid) administered as an intraveno...

Cardax Pharmaceuticals Nominates Clinical Candidate Heptax for Liver Disease; Heptax Ameliorates Inflammation and Oxidative Stress Related to Liver Disease and Metabolic Syndrome

AIEA, Hawaii, July 20 /PRNewswire/ -- The Centers for Disease Control and Prevention reported this week that the prevalence of obesity among Americans is now over 26%. Obesity exacerbates a constellation of diseases including diabetes, liver disease, and heart disease, often in...

Study of Cannabinoid Medicine for Pain Found Patients Got 'High,' but Effects Not Related to Pain Relief

HONOLULU, Jan. 28 /PRNewswire/ -- Researchers at Brigham and Women's Hospital found that patients taking cannabinoid medicines for pain may be getting "high," but these effects were unrelated to relief from their pain symptoms. Results of their study, one of the first to examine the addictive...

Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate

EMERYVILLE, Calif., Sept. 12 /PRNewswire-FirstCall/ -- Bionovo, Inc. (Nasdaq: BNVI ) today announced the publishing of a paper in the journal for the American Society for Pharmacology and Experimental Therapeutics, Drug Metabolism and Disposition, entitled "Oxidative In Vitro Metabolism of Li...

Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery

SEATTLE, Aug. 26 /PRNewswire/ -- Omeros Corporation today announced the publication of the results from a Phase 1/Phase 2 trial investigating OMS103HP in arthroscopic anterior cruciate ligament (ACL) reconstruction surgery. OMS103HP is an investigational drug product that is added to arthrosco...

Quatrx Pharmaceuticals Presents Results From Ophena(TM) (Ospemifene Tablets) Phase 3 Study Related to Treatment of Symptoms of Vulvovaginal Atrophy

Results presented at the 90th annual Endocrine Society meeting show significant improvements among women affected by moderate to severe vaginal dryness and painful intercourse ANN ARBOR, Mich, June 16 /PRNewswire/ -- QuatRx Pharmaceuticals today announced detailed primary ...

Bionovo's Drug Candidate for Menopausal Symptoms Shows Effect on Neural Pathways Related to Temperature Regulation

- Results Presented at Endocrine Society 90th Annual Meeting - SAN FRANCISCO and EMERYVILLE, Calif., June 16 /PRNewswire-FirstCall/ -- Bionovo Inc. (Nasdaq: BNVI ) today announced results from in vitro studies in neurons of its drug candidate, MF101. The data were presented at the Endocr...

Genetic Immunity Announces Data Related to the DermaVir Nanomedicine Patch in the Journal of Immunology

Data Supports Use of HIV-specific T cell Precursors with High Proliferative Capacity (PHPC) Marker to Predict Reduction of Viral Load MCLEAN, Va., and BUDAPEST, Hungary, April 21 /PRNewswire/ -- Genetic Immunity(R), a US/Hungarian clinical-stage company focused on patented nanomedicines fo...

Genta Receives Key Patent Related to Oral Gallium Compound G4544

Company to Seek Buyer for Marketed Parenteral Product Ganite(R) BERKELEY HEIGHTS, N.J., April 14 /PRNewswire/ -- Genta Incorporated (Nasdaq: GNTA ) today announced that the Company has received notice that its patent application covering novel pharmaceutical gallium compositions and compl...

Micromet Announces Presentation of Five Posters Related to Its Proprietary BiTE Antibody Platform at Annual Meeting of American Association for Cancer Research

BETHESDA, Md., March 18 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI ), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, announced that five posters will be presented on April 14, 2008, at the ann...

Statement from the American Diabetes Association Related to ACCORD Trial Announcement

ACCORD data raises concerns; Group advises patients with diabetes to maintain good control of blood glucose and talk to their doctor ALEXANDRIA, Va., Feb. 6 /PRNewswire-USNewswire/ -- In response to today's announcement by the National Heart, Lung, and Blood Institute, which sponsors the A...

Recent Findings from the Framingham Offspring Study Show Low Numbers of LDL Particles (LDL-P) by NMR are Associated With Fewer Heart Disease Related Events than Equivalently Low Levels of LDL Cholesterol (LDL-C).(1)

RALEIGH, N.C., Dec. 13 /PRNewswire/ -- The most recent study from the landmark Framingham trial demonstrates the clinical significance of knowing the number of LDL particles (LDL-P) by NMR in the management of a patient's risk for heart disease. This longitudinal outcomes study shows that low ...

Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies

Study Reveals that Thoracic Endoluminal Grafting is a Feasible Alternative TO Open Surgical Repair J Vasc Surg. 2007 Sep; 46(3):413-20. Application of Endograft to Treat Thoracic Aortic Pathologies: A Single Center Experience. Rodriguez JA, Olsen DM, Shtutman A, Luca...

Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses

ANA598 demonstrates favorable preclinical antiviral, metabolic, pharmacokinetic and preliminary toxicologic properties SAN DIEGO, Sept. 11 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS ) presented preclinical data today on ANA598, a non-nucleoside inhibitor ...

Pediatric Academic Societies' Annual Meeting to Feature Data Presentations Related to MedImmune Clinical Programs in Influenza, RSV and hMPV

GAITHERSBURG, Md., May 2 /PRNewswire-FirstCall/ -- MedImmune, Inc. (Nasdaq: MEDI) today announced that seven abstracts will be presented at the 2007 Pediatric Academic Societies' (PAS) Annual Meeting demonstrating the company's commitment to advancing the science of pediatric medicine. Data are fro...

Vectibix(R) in Combination With Chemotherapy Significantly Improved Progression-Free Survival in First-Line Metastatic Colorectal Cancer

...Form 10-Q and Form 8-K. Please refer to Amgen's most recent Forms 10-K, 10-Q and 8-K for additional information on the uncertainties and risk factors related to our business. Unless otherwise noted, Amgen is providing this information as of Aug. 6, 2009 and expressly disclaims any duty to update informatio...

Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009

...or Regulus as it builds its core team and expenses related to the Company's expansion of its drug discovery a...s in 2008, including non-cash compensation expense related to stock options of $3.6 million and $6.3 million ... same periods in 2008. The increase was primarily related to revenue from its collaboration with GSK, includ...

Labopharm files New Drug Submission with Health Canada for novel antidepressant

...ks and uncertainties. Actual events could differ materially from those projected herein and depend on a number of factors, including the uncertainties related to the regulatory process in various countries for the approval of the Company's products and the successful commercialization of the products through...

2,500 Cases Completed With the Magnetic Irrigated Catheter

...bligation to update these statements for revisions or changes after the date of this release. There can be no assurance that we will recognize revenue related to our purchase orders and other commitments in any particular period or at all because some of these purchase orders and other commitments are subjec...

Nektar Therapeutics Reports Second Quarter 2009 Financial Results

...ellectual property licenses from third parties may be required in the future; (iv) the outcome of any future intellectual property or other litigation related to the company's proprietary product candidates or complex commercial agreements; (v) if the company is unable to establish and maintain collaboration...

Scientists Discover Origin of Malaria

... Until now, malaria's origin had been unclear. Although chimpanzees were known to harbor a parasite, called Plasmodium reichenowi , that is closely related to the dominant human malaria parasite, Plasmodium falciparum , most scientists assumed incorrectly that these parasites had co-existed separately in...

Society of Gynecologic Oncologists Issues White Paper on HPV Vaccine's Impact on Cervical Cancer Prevention

...ng with other organizations interested in women's health care, oncology and related fields. The Society's membership, totaling more than 1230, is primarily comprised of gynecologic oncologists, as well as other related medical specialists including medical oncologists, radiation oncologists an...

European Division of Global Top 20 Pharmaceutical Company Awards Phase III Trial to DATATRAK

...ternational, Inc. DATATRAK International, Inc. is a worldwide technology company focused on the provision of multi-component eClinical solutions and related services for the clinical trials industry. The Company delivers a complete portfolio of software products that were created in order to accelerate cli...

Neurointerventionists Expand Research to Quality of Life in Aneurysm Patients Following Minimally Invasive Coiling Treatment

...ignificantly different. However, further examination suggests that, on a scale of 0 to 100, the coiled population lost points in three specific areas related to mental well-being: 11 points in the area of social functioning; 17 points in the area of role limitations because of emotional problems; and 14 poi...

Economy is Driving Many Osteoporotic Women to Retire Later - But Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease

...ion from Amgen. Dr. Deal has received funding from Amgen for activities not related to this program. The Council encourages women to seek information ...eoporosis and bone health. The NOF's mission is to prevent osteoporosis and related fractures, to promote lifelong bone health, to help improve the lives of th...

Dirucotide Does Not Meet Primary Endpoint in Phase III MAESTRO-01 Trial in Secondary Progressive Multiple Sclerosis

... of clinical studies, the establishment of corporate alliances, the impact of competitive products and pricing, new product development, uncertainties related to the regulatory approval process and other risks detailed from time to time in the Company's ongoing quarterly and annual reporting. For further di...

Wyeth Reports Publication of Phase 3 Data for Bazedoxifene/Conjugated Estrogens, an Investigational Compound Being Studied for the Treatment of Menopausal Symptoms

...E will ever receive regulatory approval or be successfully developed and commercialized. Other risks and uncertainties include, among others, risks related to our proposed merger with Pfizer, including satisfaction of the conditions of the proposed merger on the proposed timeframe or at all, contractual r...

NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study

... clinical development of, and obtaining regulatory approval for NeurogesX' product candidates. For further information regarding these and other risks related to NeurogesX' business, investors should consult NeurogesX' filings with the Securities and Exchange Commission. NeurogesX, Inc. ...

R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies - Results Incongruent

...st common adverse events in the trial overall were related to infections, though these were generally evenly ...s, the Company's plans for further development and related matters today, July 23, 2009, at 7:00 pm EDT/ 4:00 pm PDT. A presentation related to the TASKi3 trial results is available on Rigel'...

Researchers Create First Targeted Knockout Rats Using Zinc Finger Nuclease Technology

...nd development and cancer. Along with his colleagues, Dr. Jacob's team hopes to use knockout rats to gain a better understanding of disease processes related to hypertension, heart disease, kidney failure and cancer. ZFNs are engineered proteins that induce double strand breaks at specific sites in...

Schering-Plough Announces U.S. Filing of Mometasone Furoate/Formoterol Fumarate Combination for the Maintenance Treatment of Asthma

...gs to a class of medications known as long-acting beta2-adrenergic agonists or LABAs. In patients with asthma, LABAs may increase the chance of asthma related death. Therefore, FORADIL should only be used as additional therapy for patients not adequately controlled on other asthma controller medications. ...

July 2009 Mayo Clinic Women's HealthSource Highlights Food Storage Safety, Energy Therapies and Vitamins and Minerals

...rt on Vitamins and Minerals , a supplement to the July issue of Mayo Clinic Women's HealthSource. The Special Report covers information and issues related to vitamins and minerals, including when supplements are needed, highest safe doses and research on benefits and risks. Some findings include: ...

July 2009 Mayo Clinic Health Letter Highlights a Positive Outlook, Bell's Palsy and Heart Valve Repair

...l advisable to seek emergency care to confirm a diagnosis and start treatment, which can up the odds of full recovery. The disorder is often related to a viral infection. The nerve that controls facial muscles passes through a narrow corridor of bone on its way to the face. If the nerve becomes inf...

Cardica Announces Publication of Pivotal PAS-Port(R) Proximal Anastomosis System Clinical Trial Results

...rdiac events (MACEs) reported that may possibly be related to target vessel revascularization, four (33%) may have been related to the PAS-Port system with eight (67%) potentially related to hand-sewn anastomoses. During the trial, four p...

Prospective Clinical Advantages of Trabecular Metal(TM) Technology Highlighted in Comparative Study

...red in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer's 2008 sal...

Teeth and Gums Also Benefit from the Healing Power of Aloe Vera

...a@agd.org . NOTE: Information that appears in General Dentistry , the AGD's peer-reviewed journal, AGD Impact, the AGD's newsmagazine and related press releases do not necessarily reflect the endorsement of the AGD. ...

Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus

...on. In addition, while the Company has completed delivery of ABthrax to the U.S. Strategic National Stockpile, the Company will continue to face risks related to FDA's approval of the Company's Biologics License Application for ABthrax. If the Company is unable to meet requirements associated with the ABthra...

Oncolytics Biotech(R) Inc. Announces Publication of Research on Synergistic Activity of Reovirus and Chemotherapy in NSCLC

...th respect to REOLYSIN, the Company's expectations related to the results of trials investigating delivery of...successfully commercialize REOLYSIN, uncertainties related to the research and development of pharmaceuticals and uncertainties related to the regulatory process. Investors should consul...

Velos, Inc. Releases Software to Support Cancer Centers With New Workflow and Content for NCI Clinical Trials Reporting Program

...ble research sites, sponsors, and patients to participate in a secure, integrated system platform. System users are freed of redundant data entry and related time delays associated with most clinical research today. With emphasis on workflow, Velos integrates the clinical, administrative and financial infor...

New Research Shows: Neurofeedback is an 'Evidence-Based' Treatment for ADHD

...0-189. http://www.brainclinics.com Brainclinics is specialized in Personalized Medicine, applied Neuroscience and diagnostics of Brain related disorders. Furthermore, Brainclinics is specialized in innovative new - evidence-based - treatments such as rTMS for Depression and Neurofeedback for ...